Achmea Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Achmea Investment Management's RGEN Position: Q3 2023 in Review
Achmea Investment Management sold out of Repligen (RGEN) in Q3 2023, closing a stake of 309 shares — an estimated $44K sold.
Achmea Investment Management first reported a position in RGEN in Q4 2022 and held it in 3 quarters. The position peaked at $52K in Q1 2023. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.
- Achmea Investment Management reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
- Achmea Investment Management sold 309 Repligen shares in Q3 2023, an estimated $44K.
- Achmea Investment Management first reported a position in Repligen in Q4 2022 and held it in 3 quarters.
- Achmea Investment Management's Repligen position peaked at $52K in Q1 2023.
- 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.
Based on Achmea Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.